Tag: Ajay Tandon
July 7, 2017
Q BioMed Inc : SeeThruEquity Issues Update on Q BioMed Inc. (QBIO)
SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it...
August 18, 2016
SeeThruEquity Issues Update on BioSig Technologies Highlighting Companys Technology Being Featured in Mayo Clinic Research
NEW YORK, NY / ACCESSWIRE / August 18, 2016 / SeeThruEquity, a leading independent equity research and corporate access firm...
July 27, 2016
SeeThru Equity Initiates Coverage of Q BioMed Inc. Price Target $3.85
Q BioMed Inc. (OTCQB:QBIO) is focused on identifying, acquiring and licensing attractive biomedical assets from small private companies and academia,...
July 20, 2016
SeeThruEquity Issues Update on DelMar Pharmaceuticals, Inc. Highlighting Recent Uplisting to Nasdaq
NEW YORK, NY / ACCESSWIRE / July 20, 2016 / SeeThruEquity, a leading New York City based independent equity research...
April 14, 2016
SeeThruEquity Issues Update on DelMar Pharmaceuticals Highlighting Partnership with MD Anderson
SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public... November 19, 2014